i
i
Up-to-date Information
Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html
Johnson & Johnson’s Janssen COVID-19 vaccine overview and safety
-
Oct. 4, 2021
Details:
-
Corporate Authors:
-
Description:cdc:105457
Updated Oct. 4, 2021
CDC now recommends that people aged 65 years and older, residents aged 18 years and older in long-term care settings, and people aged 50–64 years with underlying medical conditions should receive a booster shot of Pfizer-BioNTech’s COVID-19 Vaccine at least 6 months after completing their Pfizer-BioNTech primary series. Other groups may receive a booster shot based on their individual risk and benefit. Learn more.
Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 Vaccine: Women younger than 50 years old should especially be aware of the rare risk of blood clots with low platelets after vaccination. There are other COVID-19 vaccines available for which this risk has not been seen.
-
Subjects:
-
Document Type:
-
Name as Subject:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: